Kristen Santiago
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kristen Santiago has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Jennifer Cheng
Department of Physiatry Hospital for Special Surgery New York New York USA
6 shared publications - Bridget Jivanelli
B. Jivanelli, Hospital for Special Surgery, New York, New York, USA
3 shared publications - Daphne I. Ling
Hospital for Special Surgery, New York, NY
3 shared publications - Ellen Casey
Department of Physiatry, Hospital for Special Surgery, New York, New York
3 shared publications Jennifer Cheng
3 shared publicationsZafir Abutalib
Biostatistics Core Hospital for Special Surgery New York NY USA
3 shared publications
Latest Publications
Prevalence of rapidly progressive osteoarthritis of the hip following intra‐articular steroid injections
Introduction: Numerous studies have indicated that intra‐articular steroid injections to the hip are beneficial for short‐term pain relief. However, recent studies have drawn concerns of rapidly progressive osteoarthritis of the hip (RPOH) following intra‐articular steroid injections. The prevalence of RPOH following intra‐articular steroid injections varies widely in the literature.Objective: To identify the prevalence of RPOH following intra‐articular steroid injections, and to compare baseline characteristics between patients with and without RPOH.Design: Case series.Setting: Tertiary academic hospital.Patients: A total of 924 patients (median [interquartile range; IQR] age: 59 [45‐70] years; 579 female) who received an intra‐articular hip steroid/anesthetic injection from January 2016 to March 2018 and had available pre‐ and post‐injection imaging (prior to surgical intervention) were included in the study.Interventions: Baseline and injection‐related data—including demographics, age, body mass index, medical history, laterality, and steroid type—were collected from electronic medical records.Main Outcome Measures: Post‐injection RPOH was determined via imaging review by a physiatry fellow, followed by an attending physiatrist and a musculoskeletal radiologist to confirm findings.Results: The majority of patients received unilateral injections into the hip, and the most common steroids used were triamcinolone and methylprednisolone. Review of pre‐ and post‐injection imaging revealed 26 cases of RPOH, for an overall prevalence of 2.8% (95% confidence interval [CI] 1.9%‐4.1%). Compared to those without RPOH, patients with RPOH were significantly older (median age [IQR]: 64 [60‐73] vs. 59 [44‐70] years, p = .003) and had a shorter duration of symptoms prior to their injections (median [IQR]: 3 vs. 12 [6‐36] months, p < .001). Adjusted regression analyses showed that age was associated with greater odds of RPOH (odds ratio [OR], 95% CI: 1.04, 1.01 to 1.07; p = .003).Conclusions: The prevalence of RPOH following intra‐articular steroid injections into the hip was lower than previously reported but still clinically relevant. This should be considered when counseling patients prior to intra‐articular hip steroid injections.
Prevalence of rapidly progressive osteoarthritis of the hip following intra‐articular steroid injections
Introduction: Numerous studies have indicated that intra‐articular steroid injections to the hip are beneficial for short‐term pain relief. However, recent studies have drawn concerns of rapidly progressive osteoarthritis of the hip (RPOH) following intra‐articular steroid injections. The prevalence of RPOH following intra‐articular steroid injections varies widely in the literature.Objective: To identify the prevalence of RPOH following intra‐articular steroid injections, and to compare baseline characteristics between patients with and without RPOH.Design: Case series.Setting: Tertiary academic hospital.Patients: A total of 924 patients (median [interquartile range; IQR] age: 59 [45‐70] years; 579 female) who received an intra‐articular hip steroid/anesthetic injection from January 2016 to March 2018 and had available pre‐ and post‐injection imaging (prior to surgical intervention) were included in the study.Interventions: Baseline and injection‐related data—including demographics, age, body mass index, medical history, laterality, and steroid type—were collected from electronic medical records.Main Outcome Measures: Post‐injection RPOH was determined via imaging review by a physiatry fellow, followed by an attending physiatrist and a musculoskeletal radiologist to confirm findings.Results: The majority of patients received unilateral injections into the hip, and the most common steroids used were triamcinolone and methylprednisolone. Review of pre‐ and post‐injection imaging revealed 26 cases of RPOH, for an overall prevalence of 2.8% (95% confidence interval [CI] 1.9%‐4.1%). Compared to those without RPOH, patients with RPOH were significantly older (median age [IQR]: 64 [60‐73] vs. 59 [44‐70] years, p = .003) and had a shorter duration of symptoms prior to their injections (median [IQR]: 3 vs. 12 [6‐36] months, p < .001). Adjusted regression analyses showed that age was associated with greater odds of RPOH (odds ratio [OR], 95% CI: 1.04, 1.01 to 1.07; p = .003).Conclusions: The prevalence of RPOH following intra‐articular steroid injections into the hip was lower than previously reported but still clinically relevant. This should be considered when counseling patients prior to intra‐articular hip steroid injections.
Ultrasound‐guided percutaneous needle tenotomy (PNT) alone versus PNT plus platelet‐rich plasma injection for the treatment of chronic tendinosis: A randomized controlled trial
Background: Tendinosis is a chronic degenerative condition. Current research suggests both percutaneous needle tenotomy (PNT) and leukocyte‐rich platelet‐rich plasma (LR‐PRP) may be effective treatments for chronic tendinosis, but no studies have assessed the effectiveness of PNT alone versus PNT with intratendinous LR‐PRP for multiple tendon types in a single study.Objective: To assess the efficacy of PNT versus PNT + LR‐PRP to treat chronic tendinosis.Study Design: Double‐blind, randomized, controlled comparative treatment study.Setting: Primary academic institution.Participants: A convenience sample of 40 participants who had chronic tendinosis (rotator cuff, wrist extensor, wrist flexor, hip abductor, proximal hamstring, patellar, or Achilles) confirmed via ultrasound, failed conservative treatment, and did not have tendon tears, known coagulopathy, or systemic illnesses.Interventions: Participants were randomly assigned to PNT (n = 19) or PNT + LR‐PRP (n = 21). Participants and outcomes assessors were blinded to treatment assignments. PNT was performed with 20–30 passes of a 22‐gauge needle under ultrasound guidance, with 1% lidocaine given outside the tendon. LR‐PRP was processed from whole blood (30–60 mL) and injected into the affected tendon using the same PNT technique.Main Outcome Measures: Primary outcome was current numerical rating scale pain at 6 weeks. Secondary outcomes were average pain, function, general well‐being, and sleep quality at 6, 52, and 104 weeks.Results: Baseline characteristics were similar between groups. Overall, there were no significant differences between groups over time for any of the outcomes (P > .05). Between‐group analyses showed significantly lower current and average pain after PNT compared to PNT + LR‐PRP at 6 weeks (estimated‐mean [SE]: 3.1[0.4] vs. 4.6[0.6], P = .04; 3.4[0.4] vs. 4.9[0.5], P = .03) only. Adverse event rates were low (PNT‐3.9%; PNT + LR‐PRP‐5.0%) and related primarily to postprocedural pain and inflammation.Conclusions: Although pain scores were lower after PNT compared to PNT + LR‐PRP at 6 weeks, there were no between‐group differences in outcomes at 52 or 104 weeks.
Ultrasound‐guided percutaneous needle tenotomy (PNT) alone versus PNT plus platelet‐rich plasma injection for the treatment of chronic tendinosis: A randomized controlled trial
Background: Tendinosis is a chronic degenerative condition. Current research suggests both percutaneous needle tenotomy (PNT) and leukocyte‐rich platelet‐rich plasma (LR‐PRP) may be effective treatments for chronic tendinosis, but no studies have assessed the effectiveness of PNT alone versus PNT with intratendinous LR‐PRP for multiple tendon types in a single study.Objective: To assess the efficacy of PNT versus PNT + LR‐PRP to treat chronic tendinosis.Study Design: Double‐blind, randomized, controlled comparative treatment study.Setting: Primary academic institution.Participants: A convenience sample of 40 participants who had chronic tendinosis (rotator cuff, wrist extensor, wrist flexor, hip abductor, proximal hamstring, patellar, or Achilles) confirmed via ultrasound, failed conservative treatment, and did not have tendon tears, known coagulopathy, or systemic illnesses.Interventions: Participants were randomly assigned to PNT (n = 19) or PNT + LR‐PRP (n = 21). Participants and outcomes assessors were blinded to treatment assignments. PNT was performed with 20–30 passes of a 22‐gauge needle under ultrasound guidance, with 1% lidocaine given outside the tendon. LR‐PRP was processed from whole blood (30–60 mL) and injected into the affected tendon using the same PNT technique.Main Outcome Measures: Primary outcome was current numerical rating scale pain at 6 weeks. Secondary outcomes were average pain, function, general well‐being, and sleep quality at 6, 52, and 104 weeks.Results: Baseline characteristics were similar between groups. Overall, there were no significant differences between groups over time for any of the outcomes (P > .05). Between‐group analyses showed significantly lower current and average pain after PNT compared to PNT + LR‐PRP at 6 weeks (estimated‐mean [SE]: 3.1[0.4] vs. 4.6[0.6], P = .04; 3.4[0.4] vs. 4.9[0.5], P = .03) only. Adverse event rates were low (PNT‐3.9%; PNT + LR‐PRP‐5.0%) and related primarily to postprocedural pain and inflammation.Conclusions: Although pain scores were lower after PNT compared to PNT + LR‐PRP at 6 weeks, there were no between‐group differences in outcomes at 52 or 104 weeks.
Menstrual Irregularity, Hormonal Contraceptive Use, and Bone Stress Injuries in Collegiate Female Athletes in the United States
Background: Menstrual irregularity (MI) is common in female athletes and is a component of the Female Athlete Triad (Triad). Many athletes with the Triad are started on hormonal contraceptives (HC) for MI, but this interferes with the ability to monitor menstrual cycle regularity and can mask other causes of MI. There are limited studies investigating the relationship between MI, HC use, and injury in female collegiate athletes.Objective: To examine the prevalence of and relationship between HC use, MI, and bone stress injuries in female collegiate athletes in the United States.Design: Cross‐sectional study.Setting: Online survey.Participants: 1020 U.S. female collegiate athletes (age ≥ 18 years).Methods or Interventions: Assessment of risk factors for menstrual irregularity and bone stress injuries was conducted via a one‐time survey.Main Outcome Measures: HC use, MI, history of stress fractures.Results: Current HC use prevalence was 65% (95% confidence interval [CI], 61.9%, 67.8%). Of all athletes, 47% reported past MI. Of the athletes who were not currently using HCs, 32% had current MI. Compared with athletes without past MI, more athletes with past MI reported current HC use (73% vs. 57%) and indicated menstrual cycle consistency as the primary reason for use (24% vs. 4%) (P < .001). Additionally, 25% of athletes reported a history of stress fractures, which was associated with lean/aesthetic sports participation (odds ratio [95% CI]: 1.9 [1.4, 2.5]; P < .001) and less oral contraceptive pill (OCP) use (0.7 [0.5, 1.0]; P = .043). Compared with OCPs, injectable HCs were associated with greater odds of a history of stress fractures (4.5[1.6, 12.3]; P = .004).Conclusions: HC use was prevalent among this cohort of female collegiate athletes, and almost half of the athletes reported past MI. A goal of menstrual cycle regularity was cited by 24% of athletes as a primary reason to use HCs, which shows that more athlete education is needed to avoid masking MI and the Triad with HCs. Further studies elucidating the relationship between HC use, MI, and sports‐related injury are warranted.
Menstrual Irregularity, Hormonal Contraceptive Use, and Bone Stress Injuries in Collegiate Female Athletes in the United States
Background: Menstrual irregularity (MI) is common in female athletes and is a component of the Female Athlete Triad (Triad). Many athletes with the Triad are started on hormonal contraceptives (HC) for MI, but this interferes with the ability to monitor menstrual cycle regularity and can mask other causes of MI. There are limited studies investigating the relationship between MI, HC use, and injury in female collegiate athletes.Objective: To examine the prevalence of and relationship between HC use, MI, and bone stress injuries in female collegiate athletes in the United States.Design: Cross‐sectional study.Setting: Online survey.Participants: 1020 U.S. female collegiate athletes (age ≥ 18 years).Methods or Interventions: Assessment of risk factors for menstrual irregularity and bone stress injuries was conducted via a one‐time survey.Main Outcome Measures: HC use, MI, history of stress fractures.Results: Current HC use prevalence was 65% (95% confidence interval [CI], 61.9%, 67.8%). Of all athletes, 47% reported past MI. Of the athletes who were not currently using HCs, 32% had current MI. Compared with athletes without past MI, more athletes with past MI reported current HC use (73% vs. 57%) and indicated menstrual cycle consistency as the primary reason for use (24% vs. 4%) (P < .001). Additionally, 25% of athletes reported a history of stress fractures, which was associated with lean/aesthetic sports participation (odds ratio [95% CI]: 1.9 [1.4, 2.5]; P < .001) and less oral contraceptive pill (OCP) use (0.7 [0.5, 1.0]; P = .043). Compared with OCPs, injectable HCs were associated with greater odds of a history of stress fractures (4.5[1.6, 12.3]; P = .004).Conclusions: HC use was prevalent among this cohort of female collegiate athletes, and almost half of the athletes reported past MI. A goal of menstrual cycle regularity was cited by 24% of athletes as a primary reason to use HCs, which shows that more athlete education is needed to avoid masking MI and the Triad with HCs. Further studies elucidating the relationship between HC use, MI, and sports‐related injury are warranted.
- Open Access
- 1 February 2021
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 224 (2) , S355
561 The effect of a postpartum diastasis rectus strengthening program
- 1 February 2021
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 224 (2) , S355
Open Access561 The effect of a postpartum diastasis rectus strengthening program
- 2 January 2021
- Published by Taylor & Francis in The Physician and Sportsmedicine
- Vol. 50 (1) , 11-19
Systematic review and meta-analysis of sex-based differences for concussion incidence in soccer
To compare concussion incidence in male and female soccer players due to the specific concussion-causing activity. PubMed, EMBASE, and Cochrane Library were searched for studies published between J...
- 2 January 2021
- Published by Taylor & Francis in The Physician and Sportsmedicine
- Vol. 50 (1) , 11-19
Systematic review and meta-analysis of sex-based differences for concussion incidence in soccer
To compare concussion incidence in male and female soccer players due to the specific concussion-causing activity. PubMed, EMBASE, and Cochrane Library were searched for studies published between J...
Cellular and Clinical Analyses of Autologous Bone Marrow Aspirate Injectate for Knee Osteoarthritis: A Pilot Study
Introduction: Knee osteoarthritis (OA) is characterized by pain and functional deficits. Common conservative strategies include medications, physical therapy, and intra‐articular injections. Recently, treatment using autologous cell injections has increased.Objective: To characterize the cellular content of bone marrow aspirate (BMA) and to evaluate the effect of intra‐articular autologous BMA injections in patients with mild knee OA.Design: Prospective pilot observational study.Setting: Academic institution.Patients: Eleven patients with unilateral or bilateral mild knee OA (15 knees) were included in the cellular analysis. Ten patients (13 knees) were included in the overall (cellular and clinical) analysis.Interventions: BMA was aspirated from patients’ iliac crests and then injected intra‐articularly under fluoroscopic and/or ultrasound guidance. BMA samples were analyzed using flow cytometry, colony forming unit (CFU) assays, and enzyme‐linked immunosorbent assays. Questionnaires assessing pain and function were administered preinjection and at 1, 3, 6, and 12 months postinjection. Side effects and satisfaction were assessed.Main Outcome Measures: Total nucleated cell (TNC) concentration, mesenchymal stem cell (MSC) concentration, CFU count, and interleukin‐1 receptor antagonist (IL‐1Ra) concentration.Results: BMA sample analyses revealed wide ranges in TNC concentration (173300‐4 491 050 cells/mL), MSC concentration (0‐500 cells/mL), CFUs (0‐19), and IL‐1Ra concentration (2806‐29 394 pg/mL). Improvements in Knee Injury and Osteoarthritis Outcomes Score for Joint Replacement were observed throughout the 12‐month follow‐up period (F[4,12] = 12.29, P < .001). Additionally, current, usual, best, and worst numerical rating scale pain scores significantly decreased over time (P < .001). Patient satisfaction was high (range: 8.1 ± 2.1‐8.8 ± 1.9), and side effects were uncommon.Conclusions: The cellular content of BMA samples varied widely between patients and was lower than the anticipated yield reported by the device's manufacturer. However, intra‐articular BMA injections for knee OA in a small pilot cohort appeared to be safe with potential therapeutic value. Larger, prospective, double‐blinded studies are warranted.
Cellular and Clinical Analyses of Autologous Bone Marrow Aspirate Injectate for Knee Osteoarthritis: A Pilot Study
Introduction: Knee osteoarthritis (OA) is characterized by pain and functional deficits. Common conservative strategies include medications, physical therapy, and intra‐articular injections. Recently, treatment using autologous cell injections has increased.Objective: To characterize the cellular content of bone marrow aspirate (BMA) and to evaluate the effect of intra‐articular autologous BMA injections in patients with mild knee OA.Design: Prospective pilot observational study.Setting: Academic institution.Patients: Eleven patients with unilateral or bilateral mild knee OA (15 knees) were included in the cellular analysis. Ten patients (13 knees) were included in the overall (cellular and clinical) analysis.Interventions: BMA was aspirated from patients’ iliac crests and then injected intra‐articularly under fluoroscopic and/or ultrasound guidance. BMA samples were analyzed using flow cytometry, colony forming unit (CFU) assays, and enzyme‐linked immunosorbent assays. Questionnaires assessing pain and function were administered preinjection and at 1, 3, 6, and 12 months postinjection. Side effects and satisfaction were assessed.Main Outcome Measures: Total nucleated cell (TNC) concentration, mesenchymal stem cell (MSC) concentration, CFU count, and interleukin‐1 receptor antagonist (IL‐1Ra) concentration.Results: BMA sample analyses revealed wide ranges in TNC concentration (173300‐4 491 050 cells/mL), MSC concentration (0‐500 cells/mL), CFUs (0‐19), and IL‐1Ra concentration (2806‐29 394 pg/mL). Improvements in Knee Injury and Osteoarthritis Outcomes Score for Joint Replacement were observed throughout the 12‐month follow‐up period (F[4,12] = 12.29, P < .001). Additionally, current, usual, best, and worst numerical rating scale pain scores significantly decreased over time (P < .001). Patient satisfaction was high (range: 8.1 ± 2.1‐8.8 ± 1.9), and side effects were uncommon.Conclusions: The cellular content of BMA samples varied widely between patients and was lower than the anticipated yield reported by the device's manufacturer. However, intra‐articular BMA injections for knee OA in a small pilot cohort appeared to be safe with potential therapeutic value. Larger, prospective, double‐blinded studies are warranted.
- 17 October 2019
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 478 (7) , 1469-1479
Women Are at Higher Risk for Concussions Due to Ball or Equipment Contact in Soccer and Lacrosse
Background: There is ample evidence to suggest sex- and gender-based differences in the incidence of sports-related concussions. The mechanisms of concussion may vary between male and female athletes and contribute to this observed difference. Understanding the underlying etiology by pooling data from primary studies across different settings and sport types will inform interventions that can reduce concussion rates. Questions/purposes: Specifically, we asked: (1) In which sports are female athletes less likely to experience concussions from player contact? (2) In which sports are female athletes more likely to experience concussions because of ball or equipment contact? Methods: PubMed, EMBASE, and Cochrane Library databases were searched to identify articles published from January 2000 to December 2018. Ten studies met the inclusion criteria, which were studies that reported concussion incidence by mechanism for both male and female athletes. Exclusion criteria included non-English studies, conference abstracts, and studies on non-sports related concussions. The sports represented by the 10 studies included ice hockey (n = 4), soccer (n = 5), basketball (n = 4), baseball/softball (n = 4), and lacrosse (n = 5). The rate ratio was calculated as the incidence rate in female athletes/male athletes for each concussion mechanism or activity. Data were pooled using the DerSimonian-Laird random-effects model. Study quality was assessed with the Newcastle-Ottawa Scale. Results: Female athletes were at lower risk of player-contact-induced concussions in lacrosse (pooled rate ratio 0.33 [95% CI 0.25 to 0.43]; p < 0.001), basketball (pooled rate ratio 0.86 [95% CI 0.76 to 0.97]; p = 0.01), ice hockey (pooled rate ratio 0.64 [95% CI 0.56 to 0.73]; p < 0.001), soccer (pooled rate ratio 0.70 [95% CI 0.66 to 0.75]; p < 0.001), and soccer heading (pooled rate ratio 0.80 [95% CI 0.72 to 0.90]; p < 0.001); in these sports, men were at higher risk of concussions from player contact. Female athletes were more likely to experience concussions because of ball or equipment contact in lacrosse (pooled rate ratio 3.24 [95% CI 2.10 to 4.99]; p < 0.001), soccer (pooled rate ratio 2.04 [95% CI 1.67 to 2.49]; p < 0.001), and soccer heading (pooled rate ratio 2.63 [95% CI 1.84 to 3.77]; p < 0.001). Conclusions: The mechanism or activity underlying concussions differs between male and female athletes across different sports. This finding remains the same regardless of whether there are rule differences between the men’s and women’s games. The implementation of other interventions are required to further ensure player safety, including protective head equipment, concussion prevention training, or rules limiting player contact in the men’s game. Level of Evidence: Level III, retrospective study.
- 17 October 2019
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 478 (7) , 1469-1479
Women Are at Higher Risk for Concussions Due to Ball or Equipment Contact in Soccer and Lacrosse
Background: There is ample evidence to suggest sex- and gender-based differences in the incidence of sports-related concussions. The mechanisms of concussion may vary between male and female athletes and contribute to this observed difference. Understanding the underlying etiology by pooling data from primary studies across different settings and sport types will inform interventions that can reduce concussion rates. Questions/purposes: Specifically, we asked: (1) In which sports are female athletes less likely to experience concussions from player contact? (2) In which sports are female athletes more likely to experience concussions because of ball or equipment contact? Methods: PubMed, EMBASE, and Cochrane Library databases were searched to identify articles published from January 2000 to December 2018. Ten studies met the inclusion criteria, which were studies that reported concussion incidence by mechanism for both male and female athletes. Exclusion criteria included non-English studies, conference abstracts, and studies on non-sports related concussions. The sports represented by the 10 studies included ice hockey (n = 4), soccer (n = 5), basketball (n = 4), baseball/softball (n = 4), and lacrosse (n = 5). The rate ratio was calculated as the incidence rate in female athletes/male athletes for each concussion mechanism or activity. Data were pooled using the DerSimonian-Laird random-effects model. Study quality was assessed with the Newcastle-Ottawa Scale. Results: Female athletes were at lower risk of player-contact-induced concussions in lacrosse (pooled rate ratio 0.33 [95% CI 0.25 to 0.43]; p < 0.001), basketball (pooled rate ratio 0.86 [95% CI 0.76 to 0.97]; p = 0.01), ice hockey (pooled rate ratio 0.64 [95% CI 0.56 to 0.73]; p < 0.001), soccer (pooled rate ratio 0.70 [95% CI 0.66 to 0.75]; p < 0.001), and soccer heading (pooled rate ratio 0.80 [95% CI 0.72 to 0.90]; p < 0.001); in these sports, men were at higher risk of concussions from player contact. Female athletes were more likely to experience concussions because of ball or equipment contact in lacrosse (pooled rate ratio 3.24 [95% CI 2.10 to 4.99]; p < 0.001), soccer (pooled rate ratio 2.04 [95% CI 1.67 to 2.49]; p < 0.001), and soccer heading (pooled rate ratio 2.63 [95% CI 1.84 to 3.77]; p < 0.001). Conclusions: The mechanism or activity underlying concussions differs between male and female athletes across different sports. This finding remains the same regardless of whether there are rule differences between the men’s and women’s games. The implementation of other interventions are required to further ensure player safety, including protective head equipment, concussion prevention training, or rules limiting player contact in the men’s game. Level of Evidence: Level III, retrospective study.
- Open Access
- 30 September 2019
- Published by SAGE Publications in Sports Health: A Multidisciplinary Approach
- Vol. 11 (6) , 486-491
Sex-Based Differences in the Incidence of Sports-Related Concussion: Systematic Review and Meta-analysis
The incidence of sports-related concussion in females has been increasing in recent years. To conduct a meta-analysis on sex-based differences in concussion incidence in various sports and to determine the effects of study design (retrospective vs prospective), setting (competition vs practice), and population (university and above vs high school and below) via a meta-regression. PubMed (Medline), EMBASE, and Cochrane Library databases were searched from January 2000 to January 2018. Studies reporting sports-related concussion incidence data for both males and females (age ≥10 years) were included. Systematic review with meta-analysis and meta-regression. Level 4. The rate ratio was calculated as the concussion rate in females/males. Data were pooled using the DerSimonian-Laird random-effects model. Thirty-eight studies met the eligibility criteria and were included in the meta-analysis. Soccer and basketball demonstrated significantly higher incidence of concussions in females compared with males (rate ratio [95% CI], 1.76 [1.43-2.16] and 1.99 [1.56-2.54], respectively; P < 0.01). Sex-based differences in concussion incidence rates for baseball/softball, ice hockey, lacrosse, swimming/diving, and track and field were not statistically significant. In the meta-regression analysis, there were no significant effects on the rate ratio when evaluating study design, setting, and population. Concussion incidence rates were significantly higher in females than in males for soccer and basketball.
- 30 September 2019
- Published by SAGE Publications in Sports Health: A Multidisciplinary Approach
- Vol. 11 (6) , 486-491
Open AccessSex-Based Differences in the Incidence of Sports-Related Concussion: Systematic Review and Meta-analysis
The incidence of sports-related concussion in females has been increasing in recent years. To conduct a meta-analysis on sex-based differences in concussion incidence in various sports and to determine the effects of study design (retrospective vs prospective), setting (competition vs practice), and population (university and above vs high school and below) via a meta-regression. PubMed (Medline), EMBASE, and Cochrane Library databases were searched from January 2000 to January 2018. Studies reporting sports-related concussion incidence data for both males and females (age ≥10 years) were included. Systematic review with meta-analysis and meta-regression. Level 4. The rate ratio was calculated as the concussion rate in females/males. Data were pooled using the DerSimonian-Laird random-effects model. Thirty-eight studies met the eligibility criteria and were included in the meta-analysis. Soccer and basketball demonstrated significantly higher incidence of concussions in females compared with males (rate ratio [95% CI], 1.76 [1.43-2.16] and 1.99 [1.56-2.54], respectively; P < 0.01). Sex-based differences in concussion incidence rates for baseball/softball, ice hockey, lacrosse, swimming/diving, and track and field were not statistically significant. In the meta-regression analysis, there were no significant effects on the rate ratio when evaluating study design, setting, and population. Concussion incidence rates were significantly higher in females than in males for soccer and basketball.
- 29 August 2019
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 14 (9) , 831-840
Treatment of Symptomatic Degenerative Intervertebral Discs with Autologous Platelet-Rich Plasma: Follow-Up at 5–9 Years
Aim: This study assessed pain and function at 5–9 years postinjection in a subset of patients who received intradiscal platelet-rich plasma (PRP) injections for moderate-to-severe lumbar discogenic...
- 29 August 2019
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 14 (9) , 831-840
Treatment of Symptomatic Degenerative Intervertebral Discs with Autologous Platelet-Rich Plasma: Follow-Up at 5–9 Years
Aim: This study assessed pain and function at 5–9 years postinjection in a subset of patients who received intradiscal platelet-rich plasma (PRP) injections for moderate-to-severe lumbar discogenic...